5701 - 5725 of 6466 Results
Title
Year
-
OPENTitle: Planning for Prevention of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200789Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/1.full.pdfCitation Count: 30
-
OPENTitle: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 61End Page: 67Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200786Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdfCitation Count: 21
-
OPENTitle: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdfCitation Count: 4
-
OPENTitle: An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 TherapiesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903428.98962.0aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S52.full.pdfCitation Count: 1
-
OPENTitle: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy ControlsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S8.full.pdfCitation Count: 0
-
OPENTitle: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdfCitation Count: 4
-
OPENTitle: A Severe Case of Lupus CerebritisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903100.95793.8aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S9.full.pdfCitation Count: 1
-
OPENTitle: Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 SequencesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903160.72715.2dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S17.1.full.pdfCitation Count: 2
-
OPENTitle: “Stretched Slinky” SignJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 5Start Page: e121End Page: e123Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000200075Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9647796Citation Count: 3
-
OPENTitle: Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging StudyJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 5Start Page: e85End Page: e92Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000200072Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9647803Citation Count: 6
-
OPENTitle: Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?Journal Name: Age and AgeingPublisher: Oxford University Press (OUP)Vol: 51Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1093/ageing/afab242Best OA location URL: https://academic.oup.com/ageing/article-pdf/51/1/afab242/42261496/afab242.pdfCitation Count: 16
-
OPENTitle: α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controlsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 6Issue #: 12Start Page: 2426End Page: 2436Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.50944Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.50944Citation Count: 45
-
OPENTitle: Lack of progression of beta dynamics after long‐term subthalamic neurostimulationJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 11Start Page: 2110End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51463Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51463Citation Count: 33
-
OPENTitle: Perspective: Data sharing for discoveryJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 538Issue #: 7626Start Page: S4End Page: S4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/538s4aBest OA location URL: https://www.nature.com/articles/538S4a.pdfCitation Count: 6
-
OPENTitle: Estimating motor symptom presence and severity in Parkinson’s disease from wrist accelerometer time series using ROCKET and InceptionTimeJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 19140End Page: 19140Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-025-04263-2Best OA location URL: https://www.nature.com/articles/s41598-025-04263-2.pdfCitation Count: 4
-
OPENTitle: Human pegivirus alters brain and blood immune and transcriptomic profiles of patients with Parkinson’s diseaseJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 10Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.189988Best OA location URL: https://doi.org/10.1172/jci.insight.189988Citation Count: 7
-
OPENTitle: HeteroMRI: Robust white matter abnormality classification across multi-scanner MRI dataJournal Name: GigaSciencePublisher: Oxford University Press (OUP)Vol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/gigascience/giaf092Best OA location URL: https://academic.oup.com/gigascience/article-pdf/doi/10.1093/gigascience/giaf092/64107177/giaf092.pdfCitation Count: 1
- Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression2015OPENTitle: Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progressionJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 37Issue #:Start Page: 209.e1End Page: 209.e7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.09.014Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2015.09.014Citation Count: 109
- Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease2018OPENTitle: Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 8End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6291234Citation Count: 49
-
OPENTitle: Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathologyJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 16Issue #: 2Start Page: e12589End Page: e12589Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1002/dad2.12589Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dad2.12589Citation Count: 20
-
OPENTitle: Valosin-containing-protein pathogenic variant p.R487H in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100236End Page: 100236Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100236Best OA location URL: http://dx.doi.org/10.1016/j.prdoa.2024.100236Citation Count: 1
-
OPENTitle: Potential sources of interference with the highly sensitive detection and quantification of alpha‐synuclein seeds by qRT‐QuICJournal Name: FEBS Open BioPublisher: WileyVol: 10Issue #: 5Start Page: 883End Page: 893Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/2211-5463.12844Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/2211-5463.12844Citation Count: 15
-
OPENTitle: Predictors of time to initiation of symptomatic therapy in early Parkinson's diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 7Start Page: 482End Page: 494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.317Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.317Citation Count: 29
-
OPENTitle: Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 1Start Page: 21End Page: 26Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.268Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.268Citation Count: 60
-
OPENTitle: Combining clinical and biofluid markers for early Parkinson's disease detectionJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 5Issue #: 1Start Page: 109End Page: 114Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.509Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.509Citation Count: 13